Remimazolam during induction of anesthesia in patients with severe aortic stenosis - Remimazolam during induction of anesthesia in patients with severe aortic stenosis

agoya City University Graduate School of Medical Sciences, Department of Anesthesiology and Intensive Care Medicine0 sites20 target enrollmentNovember 4, 2020

ConditionsSevere aortic stenosis

Overview

Phase: 未知
Intervention: Not specified
Conditions: Severe aortic stenosis
Sponsor: agoya City University Graduate School of Medical Sciences, Department of Anesthesiology and Intensive Care Medicine
Enrollment: 20
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

November 4, 2020

End Date

April 30, 2022

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

agoya City University Graduate School of Medical Sciences, Department of Anesthesiology and Intensive Care Medicine

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\) Patients undergoing emergency surgery (2\) Patients who are allergic to the study drugs (fentanyl, remifentanil, rocuronium, sugammadex, benzodiazepines, sevoflurane, desflurane) (3\) Patients for whom the use of remimazolam is contraindicated (patients with acute angle\-closure glaucoma, myasthenia gravis, shock, coma, and acute alcoholism with suppressed vital signs) (4\) Patients with preoperative disturbance of consciousness (5\) Patients who have been sedated preoperatively (6\) Patients deemed inappropriate by the principal investigator/associators (excluded with reasons for exclusion)